BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19690177)

  • 1. Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
    McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Couch FJ; Cunningham JM; Matsumoto ME; Rabe KG; Hammer TJ; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2549-52. PubMed ID: 19690177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
    McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Cunningham JM; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1295-302. PubMed ID: 19318433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
    Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
    Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Nucleotide Polymorphism in Adiponectin Gene and Risk of Pancreatic Adenocarcinoma.
    Mohamed AA; Omar H; Ghaffar MFA; Marie MS; Ramadan MEA; Talima SM; Daly M; Mahmoud S
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):139-143. PubMed ID: 30678425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D metabolic pathway genes and pancreatic cancer risk.
    Arem H; Yu K; Xiong X; Moy K; Freedman ND; Mayne ST; Albanes D; Arslan AA; Austin M; Bamlet WR; Beane-Freeman L; Bracci P; Canzian F; Cotterchio M; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman PJ; Hartge P; Hassan M; Helzlsouer K; Henderson B; Holly EA; Hoover R; Jacobs EJ; Kamineni A; Klein A; Klein E; Kolonel LN; Li D; Malats N; Männistö S; McCullough ML; Olson SH; Orlow I; Peters U; Petersen GM; Porta M; Severi G; Shu XO; Visvanathan K; White E; Yu H; Zeleniuch-Jacquotte A; Zheng W; Tobias GS; Maeder D; Brotzman M; Risch H; Sampson JN; Stolzenberg-Solomon RZ
    PLoS One; 2015; 10(3):e0117574. PubMed ID: 25799011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PALB2 analysis in BRCA2-like families.
    Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
    Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
    Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
    JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
    Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
    Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.
    Feng Y; Liu H; Duan B; Liu Z; Abbruzzese J; Walsh KM; Zhang X; Wei Q
    Carcinogenesis; 2019 Jun; 40(4):521-528. PubMed ID: 30794721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
    Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
    J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
    Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
    Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited pancreatic cancer syndromes.
    Solomon S; Das S; Brand R; Whitcomb DC
    Cancer J; 2012; 18(6):485-91. PubMed ID: 23187834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
    Roch AM; Schneider J; Carr RA; Lancaster WP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    J Surg Oncol; 2019 May; 119(6):777-783. PubMed ID: 30636051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.